Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT03717090 Completed - Clinical trials for Prosthetic Joint Infection

Rapid Diagnosis of Prosthetic Joint Infection by Matrix-assisted Laser Desorption

Start date: December 1, 2016
Phase:
Study type: Observational

This is a prospective cohort study. All patients presenting for periprosthetic joint infection and requiring debridement only or resection arthroplasty will be eligible. The synovial joint fluid will be sampled before the arthrotomy at the operation room. The purpose of this study will be to evaluate that 1) the concordance of organism identification by the direct identification of MALTI-TOF MS versus routine identification of MALTI-TOF MS and conventional cultures and 2) the timing of preliminary strain identification by the direct identification of MALTI-TOF MS, routine identification of MALTI-TOF MS and conventional cultures in patients with periprosthetic joint infection.

NCT ID: NCT03716804 Completed - Clinical trials for Antibiotic Resistant Infection

Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community

UTI
Start date: June 6, 2018
Phase: Phase 4
Study type: Interventional

To establish a relationship between changed prescribing pattern and associated shift in sensitivity trend of causative microbes in patients of uncomplicated urinary tract infection in a closed community

NCT ID: NCT03715569 Recruiting - Clinical trials for Hearing Loss, Sensorineural

CNS Infections Effect on the Inner Ear

Start date: December 1, 2017
Phase:
Study type: Observational

Study on patients with CNS infections.

NCT ID: NCT03715062 Completed - Clinical trials for Urinary Tract Infections

Reducing Antibiotic Prescriptions for Urinary Tract Infection in Long-Term Care Facilities

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

This cluster randomized controlled study evaluates the effect of a tailored observation, reflection and communication tool on used by long-term care facility staff on antibiotic prescription for urinary tract infection in long-term care facility residents.

NCT ID: NCT03715023 Terminated - Clinical trials for Respiratory Syncytial Virus Infections

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

TreatRSV1
Start date: November 5, 2018
Phase: Phase 2
Study type: Interventional

This study tests the effects of an experimental drug PC786 in people infected with Respiratory Syncytial Virus (RSV). PC786 may be useful in treating patients infected with RSV as it works by interfering with the way the virus multiplies. PC786 is an inhaled medicine. Participants will be treated with SoC treatment (e.g. oral ribavirin and/or IV immunoglobulin), half of the participants will receive PC786 in addition and half will receive a placebo treatment. The study will take place at multiple sites in UK and will include approximately 30 participants. The maximum study duration will be about 4 weeks.

NCT ID: NCT03710694 Completed - Clinical trials for Clostridium Difficile Infection

Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)

SHIELD
Start date: October 31, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safe use and evaluate the efficacy/performance of DAV132 in hospitalized patients at high risk for Clostridium difficile infection (CDI) and who receive fluoroquinolones (FQs) for the treatment of acute infections or for prophylaxis of febrile neutropenia.

NCT ID: NCT03707912 Completed - Clinical trials for Acute Respiratory Viral Infections

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

Start date: October 9, 2018
Phase: Phase 4
Study type: Interventional

Purpose of the study: • To obtain additional data on the efficacy and safety of Anaferon in the treatment of acute respiratory viral infections.

NCT ID: NCT03704766 Recruiting - Septic Arthritis Clinical Trials

Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis

Start date: June 28, 2016
Phase: N/A
Study type: Interventional

Differentiating between septic arthritis and other causes of joint inflammation in pediatric patients is challenging and of the utmost importance because septic arthritis requires surgical debridement as part of the treatment regimen. The current gold standard to diagnose septic arthritis in children is a positive synovial fluid culture; however, joint cultures may take several days to return. If a bacterial infection is present, it requires immediate surgical intervention in order to prevent lasting articular cartilage damage. Frequently surgeons must decide whether to surgically debride a joint before culture results are available. There is no single lab test or clinical feature that reliably indicates bacterial infection over other causes of joint inflammation. The alpha-defensin assay has shown high sensitivity and specificity for joint infection in other studies.The purpose of this study is to determine the sensitivity and specificity of several synovial biomarkers for diagnosing pediatric septic arthritis.

NCT ID: NCT03702530 Completed - Clinical trials for Necator Americanus Infection

Immunisation, Treatment and Controlled Human Hookworm Infection

ITCHHI
Start date: December 17, 2018
Phase: N/A
Study type: Interventional

24 healthy volunteers will be immunized with three times 50 L3 larvae or placebo followed by treatment with albendazol and subsequently challenged with twice 50 L3 larvae.

NCT ID: NCT03702153 Completed - Infection Clinical Trials

The Use of Synthetic Mesh in Contaminated and Infected Abdominal Wall Repairs. A Long-term Prospective Clinical Trial

Start date: January 1, 2012
Phase: N/A
Study type: Interventional

Background: Abdominal wall reconstruction in patients presenting with enteric fistulas and mesh infection is challenging. There is a consensus that synthetic mesh must be avoided in infected operations. The alternatives to using synthetic mesh, such as component separation techniques and biologic mesh, present disappointing results with expressive wound infection and hernia recurrence rates. Methods: A prospective clinical trial designed to evaluate the short and the long-term outcomes of patients submitted to elective abdominal wall repair with synthetic mesh in the dirty-infected setting, and compared to a cohort of patients submitted to clean ventral hernia repairs.